BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22054446)

  • 21. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
    Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
    J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
    Kanner WA; Barry CI; Smart CN; Frishberg DP; Binder SW; Wick MR
    Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
    Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
    Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
    Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
    G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
    Gerami P; Geraminegad P
    G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nevus versus melanoma: to FISH, or not to FISH.
    Song J; Mooi WJ; Petronic-Rosic V; Shea CR; Stricker T; Krausz T
    Adv Anat Pathol; 2011 May; 18(3):229-34. PubMed ID: 21490440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetics of melanocytic neoplasia: practical applications for diagnosis.
    Bastian BC
    Pathology; 2004 Oct; 36(5):458-61. PubMed ID: 15370116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
    Gerami P; Alsobrook JP; Palmer TJ; Robin HS
    J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular diagnostics for ambiguous melanocytic tumors.
    Shahbain H; Cooper C; Gerami P
    Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M; Urso C; Giannini A; Bondi R
    Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative genome hybridization analysis of laser-capture microdissected in situ melanoma.
    Vincek V; Xu S; Fan YS
    J Cutan Pathol; 2010 Jan; 37(1):3-7. PubMed ID: 19522846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
    Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
    Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic and mutational analyses of melanocytic tumors.
    Gerami P; Busam KJ
    Dermatol Clin; 2012 Oct; 30(4):555-66, v. PubMed ID: 23021045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Principles of dermatoscopy of pigmented skin lesions.
    Stolz W; Semmelmayer U; Johow K; Burgdorf WH
    Semin Cutan Med Surg; 2003 Mar; 22(1):9-20. PubMed ID: 12773010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological and molecular characteristics of nested melanoma of the elderly (evolved lentiginous melanoma).
    Pennacchia I; Garcovich S; Gasbarra R; Leone A; Arena V; Massi G
    Virchows Arch; 2012 Oct; 461(4):433-9. PubMed ID: 22892832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
    Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
    Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Standardized epiluminescent microscopy for differentiating melanocytic and non-melanocytic pigment nevi].
    Kreusch J; Rassner G
    Hautarzt; 1991 Feb; 42(2):77-83. PubMed ID: 1828065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions.
    Cesinaro AM; Natoli C; Grassadonia A; Tinari N; Iacobelli S; Trentini GP
    J Invest Dermatol; 2002 Jul; 119(1):187-90. PubMed ID: 12164944
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
    Zembowicz A; Yang SE; Kafanas A; Lyle SR
    Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.